Emcure subsidiary Gennova to transfer mRNA business to Immunoscript Life Science for ₹139 crore
Published on: July 11, 2026, 9:20 p.m. | Source: The Hindu Business Line
Emcure's Gennova transfers its mRNA business to Immunoscript Life Science for ₹139 crore, focusing on core biotech operations.
